Back

Safety and feasibility concerns of radiotherapy in the presence of subcutaneous implantable cardioverter-defibrillator

9 April 2024 (11:30 - 12:15)
Organised by: Logo
Congress Presentation Part of: Ventricular tachycardia 4 Radiotherapy EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Associate Professor Mateusz Tajstra

Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)

8 More presentations in this session

Presentation thumbnail
Cryoablation of ventricular tachycardia using ultra-low temperature technology: acute success and insights from the post-interventional CMR
Associate Professor B. Dinov (Giessen, DE)
Abstract Slides Video
Presentation thumbnail
Cardiac tumors with life threatening arrhythmia, an eight year single centre experience
Doctor O. Kamel (Aswan, EG)
Abstract Slides Video
Presentation thumbnail
Coronary venous ethanol ablation of refractory left ventricular summit arrhythmias: comparison with radiofrequency ablation
Doctor M. De Smet (Brugge, BE)
Abstract Slides Video
Presentation thumbnail
THerapy Efficacy in Short or long-coupled idiopathic ventricular fibrillation: an International Survey (THESIS)
Doctor O. Tovia Brodie (Jerusalem, IL)
Abstract Slides Video
Presentation thumbnail
Initial experience with ablation of ventricular arrhythmias using a pulsed-field system
Doctor P. Stojadinovic (Prague, CZ)
Abstract Slides Video

Access the full session

Session thumbnail
Ventricular tachycardia 4

The Event

Event poster

EHRA 2024

9 April 2024 11:30 CET
You may be interested in
thumbnail
Congress Presentation
Cardio-oncology challenges: radiation therapy in patients with non-transvenous cardiac implantable devices
14 April 2026
thumbnail
Congress Presentation
Mechanistic insights from preclinical models
13 April 2026
thumbnail
Congress Presentation
Extravascular defibrillator in patients not suited for the subcutaneous defibrillator.
1 September 2025
thumbnail
Congress Presentation
Dosimetric Predictors of New-Onset Atrial Fibrillation Following Thoracic Radiotherapy for Lung Cancer
12 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources